[Favorable effect of ergotamine tartrate with caffeine on headache subsequent to gaseous electroencephalography].
D001921:Brain / Q000000981:diagnostic imaging*; D002110:Caffeine / Q000627:therapeutic use*; D002317:Cardiovascular Agents; D004569:Electroencephalography; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D004878:Ergotamine; D006261:Headache / Q000209:etiology*; D006801:Humans; D011859:Radiography
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D002110:Caffeine; D004878:Ergotamine
BRAIN/radiography; CAFFEINE/therapeutic use; ERGOT ALKALOIDS/therapeutic use; HEADACHE/etiology and pathogenesis
Effet favorable du tartrate d'ergotamine caféiné sur les céphalées consécutives à l'encéphalographie gazeuse.